Legal & General Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $56.4K | Sell |
|
|||||
|
2025
Q2 | $45.7K | Buy |
|
|||||
|
2025
Q1 | $29.8K | Sell |
|
|||||
|
2024
Q4 | $388K | Sell |
|
|||||
|
2024
Q3 | $436K | Hold |
|
|||||
|
2024
Q2 | $459K | Buy |
|
|||||
|
2024
Q1 | $470K | Buy |
|
|||||
|
2023
Q4 | $566K | Sell |
|
|||||
|
2023
Q3 | $478K | Sell |
|
|||||
|
2023
Q2 | $592K | Buy |
|
|||||
|
2023
Q1 | $616K | Buy |
|
|||||
|
2022
Q4 | $621K | Sell |
|
|||||
|
2022
Q3 | $566K | Sell |
|
|||||
|
2022
Q2 | $534K | Buy |
|
|||||
|
2022
Q1 | $549K | Sell |
|
|||||
|
2021
Q4 | $634K | Buy |
|
|||||
|
2021
Q3 | $316K | Buy |
|
|||||
|
2021
Q2 | $458K | Buy |
|
|||||
|
2021
Q1 | $634K | Sell |
|
|||||
|
2020
Q4 | $555K | Hold |
|
|||||
|
2020
Q3 | $463K | Sell |
|
|||||
|
2020
Q2 | $703K | Sell |
|
|||||
|
2020
Q1 | $785K | Buy |
|
|||||
|
2019
Q4 | $646K | Buy |
|
|||||
|
2019
Q3 | $452K | Buy |
|
|||||
|
2019
Q2 | $339K | Buy |
|
|||||
|
2019
Q1 | $460K | Buy |
|
|||||
|
2018
Q4 | $492K | Buy |
|
|||||
|
2018
Q3 | $449K | Hold |
|
|||||
|
2018
Q2 | $312K | Sell |
|
|||||
|
2018
Q1 | $361K | Sell |
|
|||||
|
2017
Q4 | $591K | Buy |
|
|||||
|
2017
Q3 | $646K | Buy |
|
|||||
|
2017
Q2 | $649K | Buy |
|
|||||
|
2017
Q1 | $576K | Buy |
|
|||||
|
2016
Q4 | $448K | Buy |
|